126 top medical experts on Leydig Cell Hypoplasia across 14 countries and 2 U.S. states, including 10 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Leydig Cell Hypoplasia: A rare, 46,XY disorder of sex development due to impaired androgen production characterized by impaired normal male sexual development. The severity of the disorder varies and can manifest in its severe form with complete 46,XY male pseudohermaphroditism, including low testosterone and high luteinizing hormone levels, absent development of secondary male sex characteristics and lack of breast development. Patients with the milder form can have a wider range of phenotypes, ranging from micropenis to severe hypospadias.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Support Organizations
  4. Synonyms: 46,XY Disorder of Sex Development Due To LH Defects,  Due To LHCGR Defect Male Hypergonadotropic Hypogonadism,  LH Resistance Due To LH Receptor Deactivation,  Leydig Cell Agenesis,  Leydig Cell Hypoplasia with Male Pseudohermaphroditism,  Complete Leydig Cell Hypoplasia,  Partial Leydig Cell Hypoplasia,  Type I Leydig Cell Hypoplasia,  Type II Leydig Cell Hypoplasia,  Female Luteinizing Hormone Resistance,  Male Hypergonadotropic Hypogonadism Due To LHCGR Defect


  

        

                    


    Computing Expert Listing ...